TELIX PHARMACEUTICALS LTD
TLXNASDAQ๐ #1494 by market capEarnings Feb 19US Equity
$11.34โผ $0.27 (โ2.41%)
๐ After hours$11.53โฒ 1.68%Regular close ยท extended-hours price shownTrack TLX
Get earnings, price moves & breaking news on Telegram
24hโผ 2.4%
7dโฒ 0.7%
14dโผ 4.3%
30dโฒ 2.3%
ytdโฒ 51.4%
1yโฒ 18.2%
๐ฆMarket Cap
$3.84B
Small Cap
๐Revenue Growth (YoY)
+53.9%
High Growth
๐Gross Margin
52.2%
Healthy
๐ตFCF Margin
-6.8%
Thin
โ๏ธP/S Ratio
4.2x
Fair
Otter Score
76
Good
TELIX PHARMACEUTICALS LTD
TLXAnalyst Ratings
Price
$11.34
Total
5
Raised
0
Lowered
1
Avg PT
$18.00
H / L
$18 / $18
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-25 | โ | โ |
Wedbush | Reiterated | Outperform | 2026-09-23 | โ | โ |
Citigroup | Reiterated | Buy | 2026-07-07 | โ | โ |
UBS | Reiterated | Buy | 2025-09-23 | $20.00 | +76.40% |
JP Morgan | Downgraded | Overweight โ Neutral | 2025-08-28 | โ | โ |
Institution
HC Wainwright & Co.
Reiterated ยท Buy ยท 2026-09-25
โ
โ
Wedbush
Reiterated ยท Outperform ยท 2026-09-23
โ
โ
Citigroup
Reiterated ยท Buy ยท 2026-07-07
โ
โ
UBS
Reiterated ยท Buy ยท 2025-09-23
$20.00
+76.40%
JP Morgan
Downgraded ยท Overweight โ Neutral ยท 2025-08-28
โ
โ
One row per institution ยท price target from the firm's latest published target